As of May 22
| -0.13 / -1.98%|
The 1 analysts offering 12-month price forecasts for MusclePharm Corp have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a -6.69% decrease from the last price of 6.43.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.